Related Articles
Jaco Pastorius – Come On, Come Over
Click for Stereo: http://www.youtube.com/watch?v=PE6HmArln_k&fmt=182nd track from Jaco Pastorius’ self entitled album released in 1976 Jaco Pastorius – el…
Analysing the accuracy of pressure measurements during exercise with pulmonary artery pressure sensors – Insights from the ACTION‐MEMS study
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Insights from STEP-HFpEF Program | ESC Heart Failure 2024
Harlan Krumholz, MD, FACC, incoming Editor-in-Chief of JACC interviews Mikhail Kosiborod, MD, FACC, about Semaglutide and NTproBNP in Obesity-Related HFpEF a…
GLP1 agonists and risk of major adverse liver outcomes
To cite: Wester A, Shang Y, Toresson Grip E, et al. Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with…
Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
AbstractOrthotopic transcatheter tricuspid valve replacement (TTVR) devices have been shown to be highly effective in reducing tricuspid regurgitation (TR), and interest in this therapy is…
Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week
AbstractThe identification of the pulmonary veins as a trigger source for atrial fibrillation (AF) has established pulmonary vein isolation (PVI) as a key target for…
An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerosis:
AbstractBackgroundMost patients with atherosclerotic cardiovascular disease (ASCVD) fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals. Twice-yearly inclisiran low…
Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients
May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in…
SEQUOIA-HCM Trial Meets Primary Endpoint in Obstructive Hypertrophic Cardiomyopathy
May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised…
Innovative Health Reports Strong Growth in Cost and Environmental Savings for EP Labs at the 2024 Heart Rhythm Society Conference
May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. electrophysiology labs.…